High levels of CD44/CD133-positive cells are associated with CD204-expressing M2-type tumour-associated macrophages that generally promote tumour development, and a high co-expression of all three markers is associated with a worse overall and disease-free survival [24]. This evidence concerns the gene CD44 and neoplasm.